iPLA2 Inhibitors

iPLA, also known as PNPLA8 (patatin-like phospholipase domain containing 8) or IPLA22, is a 782 amino acid single-pass membrane protein that localizes to both the golgi and the endoplasmic reticulum and contains one patatin domain. Biochemicals that inhibit iPLA2 have many applications in biochemical and physiological research. Click on the product name to view detailed information such as the chemical structure and specific chemical properties for each of our iPLA2 Inhibitors. In stock iPLA2 Inhibitors are available for immediate shipping.

PRODUCT NAME/Application CAS Catalog # QUANTITY Price Citations RATING
An iPLA2γ inhibitor
478288-90-3 sc-222233
500 µg
1 mg

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.